Novartis Complete Financial Statements
NOVARTIND • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Novartis (NOVARTIND).
Downloads include all available records across all periods.
For market performance, see the
NOVARTIND stock price today
.
Profitability Ratios
Net Profit Margin
25.38%
2025 data
EBITDA Margin
33.42%
2025 data
Operating Margin
26.00%
2025 data
Return on Assets
10.65%
2025 data
Return on Equity
12.87%
2025 data
Balance Sheet Ratios
Current Ratio
35.52
2025 data
Debt to Equity
1.21
2025 data
Equity Ratio
82.81%
2025 data
Asset Turnover
0.42
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-0.5%
Year-over-Year
Net Profit Growth
+5.9%
Year-over-Year
EBITDA Growth
+6.8%
Year-over-Year
Expense Growth
-4.2%
Year-over-Year
Assets Growth
+2.5%
Year-over-Year
Equity Growth
+5.4%
Year-over-Year
Liabilities Growth
+2.5%
Year-over-Year
Operating Cash Flow Growth
-33.6%
Year-over-Year
Investing Cash Flow Growth
-109.1%
Year-over-Year
Financing Cash Flow Growth
+47.1%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 396 | 398 | 397 | 437 | 433 | 414 | 474 | 569 | 736 | 727 | 771 | 981 |
| Expenses | 254 | 265 | 270 | 314 | 373 | 355 | 426 | 478 | 570 | 631 | 656 | 877 |
| EBITDA | 142 | 133 | 127 | 123 | 60 | 60 | 48 | 91 | 166 | 96 | 115 | 104 |
| Operating Profit Margin % | 28.00% | 26.00% | 19.00% | 17.00% | 7.00% | 7.00% | 3.00% | 3.00% | -1.00% | 4.00% | 5.00% | 0.00% |
| Depreciation | 2 | 2 | 3 | 6 | 10 | 12 | 13 | 3 | 3 | 4 | 4 | 4 |
| Interest | 1 | 1 | 2 | 2 | 5 | 8 | 6 | 2 | 6 | 1 | 0 | 0 |
| Profit Before Tax | 139 | 130 | 123 | 115 | -4 | 40 | 29 | 86 | 158 | 92 | 111 | 93 |
| Tax | 32 | 30 | 38 | 12 | 0 | 19 | 19 | 34 | 79 | 35 | 39 | 14 |
| Net Profit | 107 | 101 | 85 | 103 | -4 | 21 | 10 | 52 | 78 | 57 | 73 | 79 |
| Earnings Per Share (₹) | 43.20 | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.10 | 62.04 | 24.75 |
Related Pages for Novartis
Additional stock information and data for NOVARTIND
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 948 | 925 | 983 | 958 | 1,002 | 1,078 | 982 | 1,111 | 1,150 | 1,433 | 1,246 |
| Current Assets | 746 | 699 | 677 | 709 | 723 | 813 | 807 | 952 | 973 | 1,264 | 1,063 |
| Fixed Assets | 5 | 7 | 19 | 24 | 64 | 76 | 15 | 5 | 6 | 7 | 9 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 943 | 918 | 964 | 934 | 938 | 1,001 | 968 | 1,106 | 1,144 | 1,426 | 1,238 |
| LIABILITIES | |||||||||||
| Total Liabilities | 948 | 925 | 983 | 958 | 1,002 | 1,078 | 982 | 1,111 | 1,150 | 1,433 | 1,246 |
| Current Liabilities | 21 | 23 | 48 | 50 | 132 | 124 | 38 | 47 | 47 | 35 | 33 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 785 | 745 | 776 | 692 | 711 | 721 | 759 | 734 | 920 | 1,194 | 1,002 |
| Share Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 | 16 | 16 |
| Reserves & Surplus | 773 | 733 | 763 | 679 | 699 | 708 | 747 | 721 | 906 | 1,178 | 986 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 75 | 113 | 45 | 39 | -69 | -23 | -194 | 161 | -41 | 57 | -60 |
| Investing Activities | -3 | 33 | -153 | 87 | 95 | 56 | 274 | 69 | 424 | -631 | 719 |
| Financing Activities | -64 | -121 | -31 | -36 | -37 | -41 | -30 | -268 | -332 | -39 | -38 |
| Net Cash Flow | 7 | 26 | -139 | 90 | -11 | -9 | 50 | -38 | 51 | -613 | 622 |